Celyad Oncology SA
CLYYF
$0.20
-$0.21-51.22%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -86.10% | -87.29% | -43.83% | -36.81% | 22.86% |
| Total Receivables | -23.23% | -29.83% | -69.44% | -65.62% | -49.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -49.26% | -53.62% | -29.68% | -20.88% | 229.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.19% | 18.05% | -45.24% | -38.40% | -83.84% |
| Total Current Assets | -68.91% | -71.58% | -45.13% | -38.27% | 10.49% |
|
|
|||||
| Total Current Assets | -68.91% | -71.58% | -45.13% | -38.27% | 10.49% |
| Net Property, Plant & Equipment | -12.20% | -19.74% | -23.59% | -14.03% | 93.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -20.07% | -27.05% | -55.18% | -49.41% | -90.54% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.99% | -24.13% | -45.88% | -39.11% | -27.43% |
| Total Assets | -51.38% | -55.56% | -42.89% | -35.75% | 3.53% |
|
|
|||||
| Total Accounts Payable | -4.77% | -12.95% | -7.09% | 4.53% | -69.50% |
| Total Accrued Expenses | 22.03% | 11.55% | -16.34% | -5.89% | -53.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -45.57% | -50.24% | -14.73% | -4.06% | -17.77% |
| Total Finance Division Other Current Liabilities | 200.90% | 175.02% | -7.15% | 4.46% | -52.58% |
| Total Other Current Liabilities | 200.90% | 175.02% | -7.15% | 4.46% | -52.58% |
| Total Current Liabilities | 68.72% | 54.22% | -9.08% | 2.28% | -61.08% |
|
|
|||||
| Total Current Liabilities | 68.72% | 54.22% | -9.08% | 2.28% | -61.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.91% | -9.42% | -20.77% | -10.86% | 133.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -25.11% | -31.54% | -11.46% | -0.39% | 31.76% |
| Total Liabilities | 0.66% | -7.99% | -11.60% | -0.55% | -15.73% |
|
|
|||||
| Common Stock & APIC | 9.61% | 0.18% | -76.64% | -73.72% | -90.50% |
| Retained Earnings | -11.56% | -1.97% | 4.81% | -7.09% | -0.29% |
| Treasury Stock & Other | 9.63% | 0.21% | 0.66% | 13.24% | 29.67% |
| Total Common Equity | -204.10% | -195.15% | -92.41% | -91.46% | 214.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -204.10% | -195.15% | -92.41% | -91.46% | 214.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -204.10% | -195.15% | -92.41% | -91.46% | 214.48% |
|
|
|||||